Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 5, Issue 5, Pages 691-706
Publisher
EMBO
Online
2013-04-18
DOI
10.1002/emmm.201202176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgotten
- (2012) Nina Raben et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- The genotype-phenotype correlation in Pompe disease
- (2012) Marian Kroos et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
- (2012) Jose A. Martina et al. Autophagy
- Autophagy in lysosomal storage disorders
- (2012) Andrew P. Lieberman et al. Autophagy
- A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
- (2012) Carmine Settembre et al. EMBO JOURNAL
- Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
- (2012) John A. Maga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- δ-Tocopherol Reduces Lipid Accumulation in Niemann-Pick Type C1 and Wolman Cholesterol Storage Disorders
- (2012) Miao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological Enhancement of α-Glucosidase by the Allosteric Chaperone N-acetylcysteine
- (2012) Caterina Porto et al. MOLECULAR THERAPY
- A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes
- (2012) Petra Tiels et al. NATURE BIOTECHNOLOGY
- The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis
- (2012) A. Roczniak-Ferguson et al. Science Signaling
- TFEB regulates autophagy: An integrated coordination of cellular degradation and recycling processes
- (2011) Carmine Settembre et al. Autophagy
- Enzyme Replacement Therapy for Pompe Disease
- (2011) Corrado Angelini et al. Current Neurology and Neuroscience Reports
- Enzyme replacement therapy for lysosomal storage diseases
- (2011) Robin H. Lachmann CURRENT OPINION IN PEDIATRICS
- Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
- (2011) Diego L. Medina et al. DEVELOPMENTAL CELL
- The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
- (2011) Suhrad G. Banugaria et al. GENETICS IN MEDICINE
- Pompe disease gene therapy
- (2011) B. J. Byrne et al. HUMAN MOLECULAR GENETICS
- Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
- (2011) Hsiang-Po Huang et al. HUMAN MOLECULAR GENETICS
- The cellular pathology of lysosomal diseases
- (2011) Timothy M Cox et al. JOURNAL OF PATHOLOGY
- Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells
- (2011) Shiho Kawagoe et al. MOLECULAR GENETICS AND METABOLISM
- β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease
- (2011) Dwight D. Koeberl et al. MOLECULAR GENETICS AND METABOLISM
- TFEB Links Autophagy to Lysosomal Biogenesis
- (2011) C. Settembre et al. SCIENCE
- Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe disease
- (2010) Nina Raben et al. Autophagy
- Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders
- (2010) Alessandro Fraldi et al. EMBO JOURNAL
- Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer
- (2010) Qingsong Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease
- (2010) Ans T. van der Ploeg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis
- (2010) Fannie W. Chen et al. PLoS One
- Immortalization of murine muscle cells from lysosomal α-glucosidase deficient mice: A new tool to study pathophysiology and assess therapeutic strategies for Pompe disease
- (2009) Gaëlle Douillard-Guilloux et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mammalian autophagy: core molecular machinery and signaling regulation
- (2009) Zhifen Yang et al. CURRENT OPINION IN CELL BIOLOGY
- Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
- (2009) S. Strothotte et al. JOURNAL OF NEUROLOGY
- Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches
- (2009) Shoichi Takikita et al. MOLECULAR GENETICS AND METABOLISM
- Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
- (2009) Priya S. Kishnani et al. MOLECULAR GENETICS AND METABOLISM
- The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
- (2009) Caterina Porto et al. MOLECULAR THERAPY
- Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease
- (2009) Yunxiang Zhu et al. MOLECULAR THERAPY
- Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
- (2009) Paul Saftig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis
- (2008) Gouri Yogalingam et al. DEVELOPMENTAL CELL
- Pompe's disease
- (2008) Ans T van der Ploeg et al. LANCET
- Therapeutic approaches in glycogen storage disease type II/pompe disease
- (2008) Benedikt Schoser et al. Neurotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search